Learning how compounded tirzepatide differs from traditional GLP-1 medications is important before you begin any program
Output: Volume to draw up (ml and IU)
PubMed Urva S, Coskun T, Loh MT, et al
Dual and Triple Agonists: The next generation of medications, such as Tirzepatide (which targets both GLP-1 and GIP receptors), are already demonstrating even greater efficacy for weight loss and blood sugar control
Egler says Nooms compounding practice is allowed when patients need medication for a personalized reason. Noom's microdosing program also offers liraglutide, Egler says, an older generation GLP-1 drug thats now available in generic form and comes in a pen
The most common side effects are stomach-related: nausea, diarrhea, vomiting, and constipation, especially during dose escalation